←
Sensorion134 posts
Sensorion avatar

Sensorion

@SensorionPharma

Sensorion is a clinical stage biopharmaceutical company developing small molecule therapeutics that address unmet need in inner ear diseases.

◷ Joined October 2017▧ 46 Photos and videos
Sensorion avatar
Sensorion@SensorionPharma·21 Sep 2018

Though not commonly talked about, disorders of the vestibules that affect balance are much more prevalent than most are aware. Here you can find quick facts and graphics about these disorders to learn more. https://t.co/9QmtXOIwqj

Sensorion avatar
Sensorion@SensorionPharma·19 Sep 2018

The different types of vestibular disorders can lead to a number of balance and falling issues in patients who suffer them. $ALSEN is developing SENS-111 to potentially help a group of patients, suffering from AUV, alleviate their balance problems. https://t.co/wpIvxFMODv

Sensorion avatar
Sensorion@SensorionPharma·17 Sep 2018

The human balance system is complex and is often taken for granted. For this reason, awareness is key to maintaining a healthy balance system. Learn more here https://t.co/K2tiDCEcZz

Sensorion avatar
Sensorion@SensorionPharma·4 Sep 2018

We are happy to announce that we will be presenting data in three posters at the 55th Inner Ear Biology Workshop on September 6th. See the press release below for more details #IEB2018 https://t.co/e0lh3hnbab

Post attachment
Sensorion avatar
Sensorion@SensorionPharma·28 Aug 2018

People react differently to the news that they or a loved one has #hearingloss. Like many other difficult diagnoses, doctors must employ a different approach for delivering this news from patient to patient https://t.co/ls3WVCd2ev

Pharmafocus avatar
⟳ Sensorion retweeted
Pharmafocus@Pharmafocus·14 Aug 2018

In our latest Working Life feature, Sensorion CEO Nawal Ouzren discusses the path she has taken throughout her career and gives her advice on replicating the successes she has realised along the way https://t.co/qNzkLFPNmo

Post attachment
Sensorion avatar
Sensorion@SensorionPharma·20 Aug 2018

Today $ALSEN received European authorization to initiate its Phase 2 trial for SENS-401 to help treat adults who suffer from sudden sensorineural #hearingloss. Read the full press release https://t.co/HJ8OuHXKSv

Post attachment